vimarsana.com
Home
Live Updates
CytoTronics launches to tackle drug discovery and phenotypic
CytoTronics launches to tackle drug discovery and phenotypic
CytoTronics launches to tackle drug discovery and phenotypic screening
Startup advances a unique CMOS-powered drug discovery platform that opens a new dimension in cell-based screening
Related Keywords
Boston ,
Massachusetts ,
United States ,
Harvard University ,
Douglas Kahn ,
Hongkun Park ,
Jeffrey Abbott ,
Donhee Ham ,
Jenna Abelli ,
Vince Wu ,
Milad Alucozai Boxone ,
Mark Hyman Jr ,
Harvard Office Of Technology Development ,
Anzu Partners ,
Milad Alucozai ,
Boxone Ventures ,
Harvard Office ,
Technology Development ,
Gordon Mckay Professor ,
Electrical Engineering ,
Harvard John ,
Mark Hyman ,
Cytotronics Board ,
Chief Business Officer ,
Duane Sword ,
Executive Chairman Douglas Kahn ,
Principal Jenna ,
Chris Petty ,
Agility Labs ,
Startups ,